| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052700 Treating gynecological blood stasis, cardio-cerebral vascular diseases, respiratory system and urinary system diseases |
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2375908C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2263663C Substituted gamma aminobutyric acids as pharmaceutical agents |
| 05/30/2006 | CA2251132C Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/30/2006 | CA2195243C Triazole compounds and the use thereof |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/30/2006 | CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/26/2006 | WO2006055711A1 Compositions containing aloe vera isolate and a prebiotic and their therapeutic application |
| 05/26/2006 | WO2006055418A1 Cyclosporine for treating mucin deficiency |
| 05/26/2006 | WO2006054912A1 Aryl(hetaryl)-3-aminomethyl-quinilone-2 derivatives in the form of no-synthetase i and cyclooxygenase-2 nhibitors, methods for the production thereof and compositions based thereon |
| 05/26/2006 | WO2006054773A1 Activation of caspase in the cell division stage of cancer cells and utilization of caspase inhibitor in anticancer agent and so on |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054710A1 Agent for ameliorating the maximum passage time through digestive tract, agent for ameliorating passage time through digestive tract and preventive for colon cancer |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006054456A1 Crystal of two-ring heterocyclic sulfonamide compound |
| 05/26/2006 | WO2006054429A1 Oral composition containing difructose anhydride |
| 05/26/2006 | WO2006053766A1 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol |
| 05/26/2006 | WO2006053646A2 Improvements in or relating to pharmaceutical compositions for local administration |
| 05/26/2006 | WO2006053383A1 Bioactive compositions |
| 05/26/2006 | WO2006036213A3 The use of gammaglobulin for the treatment of periodontal disease |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006012536A3 Methods and compositions for treating lactose intolerance |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2587957A1 Methods for purifying trans-(-)-delta-9-tetrahydrocannabinol and trans-(+)-delta-9-tetrahydrocannabinol |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
| 05/25/2006 | US20060111444 Novel halogen-substituted aminodicarboxylic acid derivatives |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia |
| 05/25/2006 | US20060111278 TFF peptides |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658839A1 Oligonucleotide/carrier combinations targeting CD40 |
| 05/24/2006 | EP1658089A2 Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
| 05/24/2006 | EP1658062A1 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1337550B1 Hepatitis c tripeptide inhibitors |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1274322B1 Composition comprising free amino acids |
| 05/24/2006 | EP1104288B1 Orally disintegrable tablet forming a viscous slurry |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | CN1777671A Novel galactooligosaccharide composition and the preparation thereof |
| 05/24/2006 | CN1777598A Polymorphs of s-omeprazole. |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777434A Agent for preventing and ameliorating constipation |
| 05/24/2006 | CN1777430A High drug load mesalazine sachet. |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775288A Medicine for treating diarrhoea |
| 05/24/2006 | CN1775279A Gynaecologic formulation and new preparing method |
| 05/24/2006 | CN1775278A Chinese medicine for treating liver disease |
| 05/24/2006 | CN1775273A Liangge preparation and new preparing method |
| 05/24/2006 | CN1775272A Infant spleen-tonifying preparation and new preparing method |
| 05/24/2006 | CN1775270A Yuying preparation and new preparing method |
| 05/24/2006 | CN1775269A Qianjin sputum-resolving preparation and new preparing method |
| 05/24/2006 | CN1775268A Kidney-tonifying preparation and preparing method |
| 05/24/2006 | CN1775264A Maiwei-dihuang preparation and new preparing method |
| 05/24/2006 | CN1775263A Qiju-dihuang preparation and new preparation method |
| 05/24/2006 | CN1775262A Guifu-Dihuang preparation and preparing method |
| 05/24/2006 | CN1775261A Mingmu-Dihuang preparation and new preparing method |
| 05/24/2006 | CN1775247A Fleece-flower root and rhizoma rehmanniae preparation and new preparing method |
| 05/24/2006 | CN1775244A Blood-cleaning detoxifying formulation and new preparing method |
| 05/24/2006 | CN1775243A Zhanhua hairy Antler formulation and new preparing method |
| 05/24/2006 | CN1775238A Anti-inflammtory anti-dysentery preparation and new preparing method |
| 05/24/2006 | CN1775217A Medicinal composition for treating Heptitis B |
| 05/24/2006 | CN1775215A Azasetron hydrochloride glucose injection formulation, and its preparing method and quality control technology |
| 05/24/2006 | CN1775211A Method and composition for reducing to xicity related to leflunomide treatment |
| 05/24/2006 | CN1775208A Liver-tonifying formulation prepared from silymarin and its preparing method |
| 05/24/2006 | CN1775088A Malt sugar |
| 05/24/2006 | CN1256981C Medicine for treating piglet white scour and its preparation method |
| 05/24/2006 | CN1256980C Medicine for treating cholecystitis |
| 05/24/2006 | CN1256977C Health-preserving brain-supplementing medicine and its preparation method |